To the best of our knowledge, this is the first meta-analysis exploring the reliability of few well-accepted inflammatory biomarkers (IL-6, CRP, and TNF-α) for differential diagnosis between VaD and AD. This evidence concerns the gene CRP and Alzheimer disease.